ChartWise Medical Systems, Inc. (www.chartwisemed.com), the award-winning industry leader in Computer-Assisted Clinical Documentation Improvement (CACDI) software, has been recognized by prominent healthcare research and analysis organization KLAS for excellence in the clinical documentation improvement technology space. For the third consecutive year, ChartWise has been named a Category Leader in the Clinical Documentation Improvement Software segment in the 2018 Best in KLAS: Software & Services report. The prestigious and highly coveted Category Leader designation is reserved for vendor solutions that lead select market segments in which at least two products meet a minimum level of KLAS Konfidence.

ChartWise set the high-water mark in the CDI Software Category with an overall KLAS score of 91.6 for the organization and its flagship ChartWise 2.0CACDI software solution. Final KLAS scores are a composite of a detailed analysis of the industry and the products, services and technologies currently available.

“Category Leader is more than a ranking; it is a recognition of vendors committed to delivering superior solutions,” said Adam Gale, president of KLAS. “It gives voice to thousands of providers who are demanding better performance, usability and interoperability in healthcare technology.”

ChartWise recently developed a unique Risk Adjustment Factor (RAF) Calculator to provide hospitals and medical systems groundbreaking technology to measure and drive CDI processes. The CACDI software innovator is also revered for supporting quality data and accurate reimbursement through it’s advanced user interface, query library and DataScan reporting, among other features. ChartWise has also begun offering ChartWise CDI Advisory Services and a specialized CACDI MasterClass to help hospitals and medical systems maximize the value and impact of their CDI programs.

“The ChartWise team has a certain restlessness that keeps the ChartWise 2.0 solution and technology relentlessly adapting and evolving, and it means a lot to have those efforts recognized again this year in the much-anticipated Best in KLAS: Software & Services report,” said Dr. Jon Elion, founder and CEO of ChartWise Medical Systems. “ChartWise is always looking at the next feature, the next service, the next bit of data we might add to help our customers secure the insight they need to be make their CDI programs as effective and efficient as possible. The work continues and we’ll definitely be looking to continue to further advance the ChartWise 2.0 technology throughout 2018.”

For additional information about the ChartWise 2.0 product, ChartWise’s suite of CDI services or to receive a comprehensive demo of the ChartWise technology, please visit http://www.chartwisemed.com/products.